Inventor · disambiguated record
Liang Zhao
Also filed as: ZHAO LIANG
7 granted patents·8 pending applications·7 citations·filing 2013–2025
75Inventor score
Files withGENENTECH INC8ENTASIS THERAPEUTICS LTD2HERNER ANDRAS2NOVARTIS AG2DEEP APPLE THERAPEUTICS INC1
Top patents by PatentIndex Score
15 records- 0176US9309245B2Beta-lactamase inhibitor compoundsENTASIS THERAPEUTICS LTD·Filed 2013·Granted Apr 12, 2016·4 cites·20 claims
- 0274US12129246B1Hydroquinazoline derivatives for the treatment of a disease or disorderNOVARTIS AG·Filed 2024·Granted Oct 29, 2024·0 cites·30 claims
- 0373US9623014B2β-lactamase inhibitor compoundsENTASIS THERAPEUTICS LTD·Filed 2016·Granted Apr 18, 2017·2 cites·22 claims
- 0471US10457654B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2017·Granted Oct 29, 2019·1 cites·19 claims
- 0568US11028075B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2019·Granted Jun 8, 2021·0 cites·10 claims
- 0668US2025122171A1Substituted Amine Compounds, Compositions and Methods of UseDEEP APPLE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0767US12275745B2Therapeutic compounds and methods of useGENENTECH INC·Filed 2022·Granted Apr 15, 2025·0 cites·20 claims
- 0858US2025171464A1Therapeutic compounds and methods of useGENENTECH INC·Filed 2025·Application pending·0 cites
- 0958US2025179063A2Selective bcl-xl protac compounds and methods of useHERNER ANDRAS·Filed 2022·Application pending·0 cites
- 1058US2024376094A2Selective bcl-xl protac compounds and methods of useHERNER ANDRAS·Filed 2022·Application pending·0 cites
- 1157US2024216513A1Fatty acid-bifunctional degrader conjugates and their methods of useNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1255US2022081423A1Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2021·Application pending·0 cites
- 1352US2020115354A1Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 1444US2022048888A1Pyrimidinyl-heteroaryloxy-naphthyl compounds and methods of useGENENTECH INC·Filed 2019·Application pending·0 cites
- 1543US10968203B2Pyrimidinyl-pyridyloxy-naphthyl compounds and methods of treating IRE1-related diseases and disordersGENENTECH INC·Filed 2018·Granted Apr 6, 2021·0 cites·41 claims
Join the waitlist — get patent alerts
Get an alert when Liang Zhao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →